229 COVID-19 Vaccines Q&A: The Two-Dose Strategy, Speeding up Rollouts, and Very Normal Side Effects episode artwork

EPISODE · Jan 8, 2021 · 15 MIN

229 COVID-19 Vaccines Q&A: The Two-Dose Strategy, Speeding up Rollouts, and Very Normal Side Effects

from Public Health On Call · host Johns Hopkins Bloomberg School of Public Health

With a shortage of COVID-19 vaccines, is it a good idea to give people just one dose now and a second dose later when there is more available? How can the process of rolling out vaccines be sped up? What do we know about potential side effects? Which vaccine should I get? Immunologist Dr. Gigi Gronvall from the Center for Health Security talks with Stephanie Desmon to answer these questions and more about COVID-19 vaccines. KEYWORDS: vaccine hesitancy; herd immunity

Episode metadata supplied by the publisher feed · Published Jan 8, 2021

Embed this episode

NOW PLAYING

229 COVID-19 Vaccines Q&A: The Two-Dose Strategy, Speeding up Rollouts, and Very Normal Side Effects

0:00 15:28

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Public Health On Call?

This episode is 15 minutes long.

When was this Public Health On Call episode published?

This episode was published on January 8, 2021.

Can I download this Public Health On Call episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!